Concepedia

Li Wang

LW

Statistics

Publications

2

Citations

69

H-Index

2

Active since

2023

Affiliations

Nanjing Medical University(Current)

Li Wang is an author at Nanjing Medical University specializing in adverse drug reaction reporting, adverse drug reaction reporting systems, and clinical pharmacology.

ORCID

Publications per year

2023–2023

2

Publications

2

A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database

Fan Zou, Chengyu Zhu, Siyu Lou et al. · Frontiers in Pharmacology · 2023 · 57 citations · Full text

, , +14

<scp>MYC</scp>‐induced cytidine metabolism regulates survival and drug resistance via <scp>cGas‐STING</scp> pathway in mantle cell lymphoma

Jin‐Hua Liang, Yimin Ren, Kai‐Xin Du et al. · British Journal of Haematology · 2023 · 12 citations · Full text

, , +17

1–2 of 2